DekaBank Deutsche Girozentrale Decreases Stock Position in Stryker Corporation (NYSE:SYK)

DekaBank Deutsche Girozentrale decreased its holdings in shares of Stryker Corporation (NYSE:SYK - Free Report) by 0.9% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 745,603 shares of the medical technology company's stock after selling 7,126 shares during the period. DekaBank Deutsche Girozentrale owned 0.20% of Stryker worth $272,962,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in SYK. Brighton Jones LLC increased its stake in shares of Stryker by 15.4% during the fourth quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company's stock valued at $1,643,000 after purchasing an additional 609 shares in the last quarter. Assetmark Inc. increased its stake in shares of Stryker by 28.1% during the fourth quarter. Assetmark Inc. now owns 1,298 shares of the medical technology company's stock valued at $467,000 after purchasing an additional 285 shares in the last quarter. Proficio Capital Partners LLC increased its stake in shares of Stryker by 46.2% during the fourth quarter. Proficio Capital Partners LLC now owns 1,656 shares of the medical technology company's stock valued at $596,000 after purchasing an additional 523 shares in the last quarter. OFI Invest Asset Management bought a new position in shares of Stryker during the fourth quarter valued at approximately $735,000. Finally, Argentarii LLC bought a new position in shares of Stryker during the fourth quarter valued at approximately $245,000. Institutional investors own 77.09% of the company's stock.

Analyst Upgrades and Downgrades

SYK has been the subject of several analyst reports. Evercore ISI raised their price target on shares of Stryker from $390.00 to $415.00 and gave the company an "outperform" rating in a research report on Tuesday. Truist Financial boosted their price objective on shares of Stryker from $390.00 to $400.00 and gave the stock a "hold" rating in a report on Monday, May 5th. BTIG Research set a $403.00 price objective on shares of Stryker and gave the stock a "buy" rating in a report on Monday, April 14th. Roth Mkm boosted their price objective on shares of Stryker from $405.00 to $456.00 and gave the stock a "buy" rating in a report on Friday, May 2nd. Finally, Citigroup restated a "buy" rating and issued a $455.00 price objective (up from $443.00) on shares of Stryker in a report on Thursday, May 22nd. Five research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, Stryker currently has an average rating of "Moderate Buy" and a consensus price target of $428.55.

Insider Buying and Selling at Stryker

In related news, Director Ronda E. Stryker sold 200,000 shares of Stryker stock in a transaction on Tuesday, May 6th. The shares were sold at an average price of $376.96, for a total transaction of $75,392,000.00. Following the transaction, the director owned 3,417,326 shares in the company, valued at approximately $1,288,195,208.96. The trade was a 5.53% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 5.90% of the company's stock.

Stryker Stock Performance

Shares of SYK stock traded up $2.62 during mid-day trading on Thursday, reaching $394.67. 1,151,644 shares of the company's stock traded hands, compared to its average volume of 1,350,087. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.00 and a current ratio of 1.64. Stryker Corporation has a 12 month low of $314.93 and a 12 month high of $406.19. The firm has a 50 day moving average price of $384.17 and a two-hundred day moving average price of $376.78. The firm has a market capitalization of $150.64 billion, a PE ratio of 53.33, a price-to-earnings-growth ratio of 2.94 and a beta of 0.91.

Stryker (NYSE:SYK - Get Free Report) last released its earnings results on Thursday, May 1st. The medical technology company reported $2.84 earnings per share for the quarter, beating analysts' consensus estimates of $2.73 by $0.11. Stryker had a net margin of 12.31% and a return on equity of 23.74%. The company had revenue of $5.87 billion for the quarter, compared to analysts' expectations of $5.68 billion. During the same quarter in the previous year, the company earned $2.50 EPS. Stryker's revenue for the quarter was up 11.9% on a year-over-year basis. On average, research analysts forecast that Stryker Corporation will post 13.47 EPS for the current year.

Stryker Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, July 31st. Investors of record on Monday, June 30th will be paid a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a dividend yield of 0.85%. The ex-dividend date of this dividend is Monday, June 30th. Stryker's dividend payout ratio (DPR) is 45.41%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.